Richard Vehe
Pediatric Rheumatology · Minneapolis, MNNPI 1972604981
Payments from drug & device makers
Across 49 payments — averaging $11,082 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$442K
- Pfizer$77K
- Novartis$16K
- Swedish Orphan Biovitrum AB$8K
Across 2 payments — averaging $2137.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4K
What the payments were for
- Food & beverage$38100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 7 | $442,334 |
| Pfizer | 31 | $77,072 |
| Novartis | 2 | $15,899 |
| Swedish Orphan Biovitrum AB | 9 | $7,693 |
How this compares
Too few pediatric rheumatology providers in Minnesotato place this figure against a meaningful peer group, so we don't.
Other pediatric rheumatology in Minneapolis
- Bryce BinstadtMinneapolis$270K
- Zachary ShaheenMinneapolis$50K
- Colleen CorrellMinneapolis$45K
- Mona RiskallaMinneapolis$6K
- Elizabeth ChalomSaint Paul$187K
- Dori AbelRochester$32
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.